ID   SAMP_HUMAN              Reviewed;         223 AA.
AC   P02743;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 2.
DT   22-JUL-2015, entry version 179.
DE   RecName: Full=Serum amyloid P-component;
DE            Short=SAP;
DE   AltName: Full=9.5S alpha-1-glycoprotein;
DE   Contains:
DE     RecName: Full=Serum amyloid P-component(1-203);
DE   Flags: Precursor;
GN   Name=APCS; Synonyms=PTX2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2987268;
RA   Mantzouranis E.C., Dowton S.B., Whitehead A.S., Edge M.D.,
RA   Bruns G.A.P., Colten H.R.;
RT   "Human serum amyloid P component. cDNA isolation, complete sequence of
RT   pre-serum amyloid P component, and localization of the gene to
RT   chromosome 1.";
RL   J. Biol. Chem. 260:7752-7756(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3029048;
RA   Ohnishi S., Maeda S., Shimada K., Arao T.;
RT   "Isolation and characterization of the complete complementary and
RT   genomic DNA sequences of human serum amyloid P component.";
RL   J. Biochem. 100:849-858(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skeletal muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 20-223.
RX   PubMed=4055725;
RA   Prelli F., Pras M., Frangione B.;
RT   "The primary structure of human tissue amyloid P component from a
RT   patient with primary idiopathic amyloidosis.";
RL   J. Biol. Chem. 260:12895-12898(1985).
RN   [8]
RP   PROTEIN SEQUENCE OF 20-49.
RX   PubMed=81686; DOI=10.1021/bi00613a030;
RA   Thompson A.R., Enfield D.L.;
RT   "Human plasma P component: isolation and characterization.";
RL   Biochemistry 17:4304-4311(1978).
RN   [9]
RP   STRUCTURE OF CARBOHYDRATE, AND MASS SPECTROMETRY.
RX   PubMed=8202534; DOI=10.1073/pnas.91.12.5602;
RA   Pepys M.B., Rademacher T.W., Amatayakul-Chantler S., Williams P.,
RA   Noble G.E., Hutchinson W.L., Hawkins P.N., Nelson S.R.,
RA   Gallimore J.R., Herbert J., Hutton T., Dwek R.A.;
RT   "Human serum amyloid P component is an invariant constituent of
RT   amyloid deposits and has a uniquely homogeneous glycostructure.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:5602-5606(1994).
RN   [10]
RP   TISSUE SPECIFICITY, AND MASS SPECTROMETRY.
RX   PubMed=15174148; DOI=10.1002/pmic.200300690;
RA   Kiernan U.A., Nedelkov D., Tubbs K.A., Niederkofler E.E., Nelson R.W.;
RT   "Proteomic characterization of novel serum amyloid P component
RT   variants from human plasma and urine.";
RL   Proteomics 4:1825-1829(2004).
RN   [11]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-51.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS).
RX   PubMed=8114934; DOI=10.1038/367338a0;
RA   Emsley J., White H.E., O'Hara B., Oliva G., Srinivasan N.,
RA   Tickle I.J., Blundell T.L., Pepys M.B., Wood S.P.;
RT   "Structure of pentameric human serum amyloid P component.";
RL   Nature 367:338-345(1994).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS).
RX   PubMed=9217261; DOI=10.1006/jmbi.1997.1075;
RA   Hohenester E., Hutchinson W.L., Pepys M.B., Wood S.P.;
RT   "Crystal structure of a decameric complex of human serum amyloid P
RT   component with bound dAMP.";
RL   J. Mol. Biol. 269:570-578(1997).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] SER-141.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Can interact with DNA and histones and may scavenge
CC       nuclear material released from damaged circulating cells. May also
CC       function as a calcium-dependent lectin.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC       Note=Binds 2 calcium ions per subunit.;
CC   -!- SUBUNIT: Homopentamer. Pentaxin (or pentraxin) have a discoid
CC       arrangement of 5 non-covalently bound subunits.
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- TISSUE SPECIFICITY: Found in serum and urine.
CC       {ECO:0000269|PubMed:15174148}.
CC   -!- PTM: N-glycosylated with a complex biantennary oligosaccharide
CC       chain with a sialic acid at the end (disialo-SAP). Monosialo-SAP
CC       as well as asioalo-SAP are also detected (PubMed:15174148).
CC       {ECO:0000269|PubMed:15174148, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- MASS SPECTROMETRY: Mass=25462.5; Mass_error=1.1;
CC       Method=Electrospray; Range=20-223;
CC       Evidence={ECO:0000269|PubMed:15174148,
CC       ECO:0000269|PubMed:8202534};
CC   -!- MASS SPECTROMETRY: Mass=25463; Mass_error=3; Method=MALDI;
CC       Range=20-223; Evidence={ECO:0000269|PubMed:15174148,
CC       ECO:0000269|PubMed:8202534};
CC   -!- MASS SPECTROMETRY: Mass=1285.78; Method=MALDI; Range=213-223;
CC       Evidence={ECO:0000269|PubMed:15174148};
CC   -!- MASS SPECTROMETRY: Mass=1186.71; Method=MALDI; Range=213-222;
CC       Evidence={ECO:0000269|PubMed:15174148};
CC   -!- DISEASE: Note=SAP is a precursor of amyloid component P which is
CC       found in basement membrane and associated with amyloid deposits.
CC   -!- SIMILARITY: Belongs to the pentaxin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 pentaxin domain. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Serum amyloid P component
CC       entry;
CC       URL="http://en.wikipedia.org/wiki/Serum_Amyloid_P_Component";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D00097; BAA00060.1; -; Genomic_DNA.
DR   EMBL; M10944; AAA60302.1; -; mRNA.
DR   EMBL; X04608; CAA28275.1; -; mRNA.
DR   EMBL; CR450313; CAG29309.1; -; mRNA.
DR   EMBL; AL445528; CAH73651.1; -; Genomic_DNA.
DR   EMBL; BT006750; AAP35396.1; -; mRNA.
DR   EMBL; BC007039; AAH07039.1; -; mRNA.
DR   EMBL; BC007058; AAH07058.1; -; mRNA.
DR   CCDS; CCDS1186.1; -.
DR   PIR; A25503; YLHUP.
DR   RefSeq; NP_001630.1; NM_001639.3.
DR   UniGene; Hs.507080; -.
DR   PDB; 1GYK; X-ray; 2.20 A; A/B/C/D/E=20-223.
DR   PDB; 1LGN; X-ray; 2.80 A; A/B/C/D/E=20-223.
DR   PDB; 1SAC; X-ray; 2.00 A; A/B/C/D/E=20-223.
DR   PDB; 2A3W; X-ray; 2.20 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P/Q/R/S/T=20-223.
DR   PDB; 2A3X; X-ray; 3.00 A; A/B/C/D/E/F/G/H/I/J=20-223.
DR   PDB; 2A3Y; X-ray; 2.00 A; A/B/C/D/E=20-223.
DR   PDB; 2W08; X-ray; 1.70 A; A/B/C/D/E=20-223.
DR   PDB; 3D5O; X-ray; 2.80 A; A/B/C/D/E=20-223.
DR   PDB; 3KQR; X-ray; 1.50 A; A/B/C/D/E=20-223.
DR   PDB; 4AVS; X-ray; 1.40 A; A/B/C/D/E=20-223.
DR   PDB; 4AVT; X-ray; 3.20 A; A/B/C/D/E/F/G/H/I/J=20-223.
DR   PDB; 4AVV; X-ray; 1.60 A; A/B/C/D/E=20-223.
DR   PDB; 4AYU; X-ray; 1.50 A; A/B/C/D/E=20-223.
DR   PDBsum; 1GYK; -.
DR   PDBsum; 1LGN; -.
DR   PDBsum; 1SAC; -.
DR   PDBsum; 2A3W; -.
DR   PDBsum; 2A3X; -.
DR   PDBsum; 2A3Y; -.
DR   PDBsum; 2W08; -.
DR   PDBsum; 3D5O; -.
DR   PDBsum; 3KQR; -.
DR   PDBsum; 4AVS; -.
DR   PDBsum; 4AVT; -.
DR   PDBsum; 4AVV; -.
DR   PDBsum; 4AYU; -.
DR   ProteinModelPortal; P02743; -.
DR   SMR; P02743; 20-223.
DR   BioGrid; 106822; 13.
DR   DIP; DIP-46911N; -.
DR   IntAct; P02743; 5.
DR   MINT; MINT-4723480; -.
DR   STRING; 9606.ENSP00000255040; -.
DR   ChEMBL; CHEMBL4929; -.
DR   GuidetoPHARMACOLOGY; 2839; -.
DR   TCDB; 1.C.92.1.2; the pentraxin (pentraxin) family.
DR   PhosphoSite; P02743; -.
DR   UniCarbKB; P02743; -.
DR   BioMuta; APCS; -.
DR   DMDM; 730704; -.
DR   DOSAC-COBS-2DPAGE; P02743; -.
DR   OGP; P02743; -.
DR   REPRODUCTION-2DPAGE; IPI00022391; -.
DR   REPRODUCTION-2DPAGE; P02743; -.
DR   SWISS-2DPAGE; P02743; -.
DR   PaxDb; P02743; -.
DR   PeptideAtlas; P02743; -.
DR   PRIDE; P02743; -.
DR   DNASU; 325; -.
DR   Ensembl; ENST00000255040; ENSP00000255040; ENSG00000132703.
DR   GeneID; 325; -.
DR   KEGG; hsa:325; -.
DR   UCSC; uc001ftv.3; human.
DR   CTD; 325; -.
DR   GeneCards; GC01P159557; -.
DR   HGNC; HGNC:584; APCS.
DR   HPA; CAB007817; -.
DR   HPA; HPA053294; -.
DR   MIM; 104770; gene.
DR   neXtProt; NX_P02743; -.
DR   PharmGKB; PA24877; -.
DR   eggNOG; NOG44770; -.
DR   GeneTree; ENSGT00760000119128; -.
DR   HOGENOM; HOG000247043; -.
DR   HOVERGEN; HBG005405; -.
DR   InParanoid; P02743; -.
DR   OMA; DHVNLIT; -.
DR   OrthoDB; EOG71RXMB; -.
DR   PhylomeDB; P02743; -.
DR   TreeFam; TF330208; -.
DR   Reactome; REACT_75925; Amyloids.
DR   ChiTaRS; APCS; human.
DR   EvolutionaryTrace; P02743; -.
DR   GeneWiki; Serum_amyloid_P_component; -.
DR   GenomeRNAi; 325; -.
DR   NextBio; 1333; -.
DR   PRO; PR:P02743; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; P02743; -.
DR   CleanEx; HS_APCS; -.
DR   ExpressionAtlas; P02743; baseline and differential.
DR   Genevisible; P02743; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; NAS:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; IDA:BHF-UCL.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:UniProtKB-KW.
DR   GO; GO:0001849; F:complement component C1q binding; IDA:BHF-UCL.
DR   GO; GO:0051082; F:unfolded protein binding; TAS:ProtInc.
DR   GO; GO:0046790; F:virion binding; IDA:BHF-UCL.
DR   GO; GO:0006953; P:acute-phase response; TAS:ProtInc.
DR   GO; GO:0051131; P:chaperone-mediated protein complex assembly; TAS:ProtInc.
DR   GO; GO:0045087; P:innate immune response; IDA:BHF-UCL.
DR   GO; GO:0044869; P:negative regulation by host of viral exo-alpha-sialidase activity; IDA:BHF-UCL.
DR   GO; GO:0044871; P:negative regulation by host of viral glycoprotein metabolic process; IDA:BHF-UCL.
DR   GO; GO:0002674; P:negative regulation of acute inflammatory response; IC:BHF-UCL.
DR   GO; GO:1903016; P:negative regulation of exo-alpha-sialidase activity; IDA:BHF-UCL.
DR   GO; GO:1903019; P:negative regulation of glycoprotein metabolic process; IDA:BHF-UCL.
DR   GO; GO:0045656; P:negative regulation of monocyte differentiation; IDA:BHF-UCL.
DR   GO; GO:0046597; P:negative regulation of viral entry into host cell; IDA:BHF-UCL.
DR   GO; GO:0048525; P:negative regulation of viral process; IDA:BHF-UCL.
DR   GO; GO:0061045; P:negative regulation of wound healing; IC:BHF-UCL.
DR   GO; GO:0006457; P:protein folding; TAS:ProtInc.
DR   Gene3D; 2.60.120.200; -; 1.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR001759; Pentaxin.
DR   InterPro; IPR030476; Pentaxin_CS.
DR   Pfam; PF00354; Pentaxin; 1.
DR   PRINTS; PR00895; PENTAXIN.
DR   SMART; SM00159; PTX; 1.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS00289; PENTAXIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amyloid; Calcium; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Lectin;
KW   Metal-binding; Polymorphism; Reference proteome; Secreted; Signal.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:4055725,
FT                                ECO:0000269|PubMed:81686}.
FT   CHAIN        20    223       Serum amyloid P-component.
FT                                /FTId=PRO_0000023540.
FT   CHAIN        20    222       Serum amyloid P-component(1-203).
FT                                /FTId=PRO_0000023541.
FT   DOMAIN       20    223       Pentaxin.
FT   METAL        77     77       Calcium 1.
FT   METAL        78     78       Calcium 1.
FT   METAL       155    155       Calcium 1.
FT   METAL       155    155       Calcium 2.
FT   METAL       156    156       Calcium 1; via carbonyl oxygen.
FT   METAL       157    157       Calcium 1.
FT   METAL       157    157       Calcium 2.
FT   METAL       167    167       Calcium 2.
FT   CARBOHYD     51     51       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19159218}.
FT                                /FTId=CAR_000169.
FT   DISULFID     55    114       {ECO:0000269|PubMed:4055725}.
FT   VARIANT     141    141       G -> S (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035814.
FT   VARIANT     155    155       E -> G.
FT                                /FTId=VAR_006054.
FT   VARIANT     158    158       S -> G.
FT                                /FTId=VAR_006055.
FT   CONFLICT    101    101       S -> P (in Ref. 1; AAA60302).
FT                                {ECO:0000305}.
FT   STRAND       26     30       {ECO:0000244|PDB:4AVS}.
FT   STRAND       38     41       {ECO:0000244|PDB:4AVS}.
FT   STRAND       49     59       {ECO:0000244|PDB:4AVS}.
FT   STRAND       66     73       {ECO:0000244|PDB:4AVS}.
FT   STRAND       76     86       {ECO:0000244|PDB:4AVS}.
FT   STRAND       89     94       {ECO:0000244|PDB:4AVS}.
FT   STRAND       97    102       {ECO:0000244|PDB:4AVS}.
FT   STRAND      111    118       {ECO:0000244|PDB:4AVS}.
FT   TURN        119    121       {ECO:0000244|PDB:4AVS}.
FT   STRAND      123    128       {ECO:0000244|PDB:4AVS}.
FT   STRAND      149    154       {ECO:0000244|PDB:4AVS}.
FT   STRAND      157    160       {ECO:0000244|PDB:4AVS}.
FT   HELIX       165    167       {ECO:0000244|PDB:4AVS}.
FT   STRAND      171    181       {ECO:0000244|PDB:4AVS}.
FT   HELIX       185    193       {ECO:0000244|PDB:4AVS}.
FT   STRAND      200    203       {ECO:0000244|PDB:4AVS}.
FT   HELIX       204    206       {ECO:0000244|PDB:4AYU}.
FT   STRAND      209    214       {ECO:0000244|PDB:4AVS}.
FT   STRAND      216    219       {ECO:0000244|PDB:4AVS}.
SQ   SEQUENCE   223 AA;  25387 MW;  6C88A515FE88B393 CRC64;
     MNKPLLWISV LTSLLEAFAH TDLSGKVFVF PRESVTDHVN LITPLEKPLQ NFTLCFRAYS
     DLSRAYSLFS YNTQGRDNEL LVYKERVGEY SLYIGRHKVT SKVIEKFPAP VHICVSWESS
     SGIAEFWING TPLVKKGLRQ GYFVEAQPKI VLGQEQDSYG GKFDRSQSFV GEIGDLYMWD
     SVLPPENILS AYQGTPLPAN ILDWQALNYE IRGYVIIKPL VWV
//
